skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 458  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Automated identification of acute hepatitis B using electronic medical record data to facilitate public health surveillance
Material Type:
Article
Add to My Research

Automated identification of acute hepatitis B using electronic medical record data to facilitate public health surveillance

PloS one, 2008-07, Vol.3 (7), p.e2626-e2626 [Peer Reviewed Journal]

COPYRIGHT 2008 Public Library of Science ;2008 Klompas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Klompas et al. 2008 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0002626 ;PMID: 18612462

Full text available

2
SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England
Material Type:
Article
Add to My Research

SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England

The Lancet Infectious Diseases, 2021-03, Vol.21 (3), p.344-353 [Peer Reviewed Journal]

2021 ;Crown Copyright © 2021 Published by Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Copyright Elsevier Limited Mar 2021 ;Crown Copyright © 2020 Published by Elsevier Ltd. All rights reserved. 2021 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30882-3 ;PMID: 33306981

Digital Resources/Online E-Resources

3
Effectiveness of maternal pertussis vaccination in England: an observational study
Material Type:
Article
Add to My Research

Effectiveness of maternal pertussis vaccination in England: an observational study

The Lancet (British edition), 2014-10, Vol.384 (9953), p.1521-1528 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright Elsevier Limited Oct 25, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)60686-3 ;PMID: 25037990 ;CODEN: LANCAO

Full text available

4
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study
Material Type:
Article
Add to My Research

Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study

Nature communications, 2022-09, Vol.13 (1), p.5736-5736, Article 5736 [Peer Reviewed Journal]

Crown 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-33378-7

Full text available

5
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study
Material Type:
Article
Add to My Research

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

The Lancet infectious diseases, 2018-04, Vol.18 (4), p.441-451 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 1, 2018 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(18)30052-5 ;PMID: 29395999

Full text available

6
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
Material Type:
Article
Add to My Research

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

The Lancet (British edition), 2016-12, Vol.388 (10061), p.2775-2782 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 3, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31921-3 ;PMID: 28100432 ;CODEN: LANCAO

Full text available

7
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
Material Type:
Article
Add to My Research

Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England

Nature medicine, 2022-04, Vol.28 (4), p.831-837 [Peer Reviewed Journal]

2022. Crown. ;Crown 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-01699-1 ;PMID: 35045566

Full text available

8
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Material Type:
Article
Add to My Research

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

BMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964

Full text available

9
Acute and Persistent Symptoms in Children With Polymerase Chain Reaction (PCR)–Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Compared With Test-Negative Children in England: Active, Prospective, National Surveillance
Material Type:
Article
Add to My Research

Acute and Persistent Symptoms in Children With Polymerase Chain Reaction (PCR)–Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Compared With Test-Negative Children in England: Active, Prospective, National Surveillance

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e191-e200 [Peer Reviewed Journal]

Crown copyright 2021. 2021 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciab991

Full text available

10
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Material Type:
Article
Add to My Research

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

New England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274

Digital Resources/Online E-Resources

11
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
Material Type:
Article
Add to My Research

Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study

The Lancet infectious diseases, 2023-04, Vol.23 (4), p.435-444 [Peer Reviewed Journal]

2023 ;Crown Copyright © 2023 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Crown Copyright © 2022 Published by Elsevier Ltd. 2023 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00729-0 ;PMID: 36436536

Full text available

12
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England
Material Type:
Article
Add to My Research

Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England

Clinical infectious diseases, 2021-03, Vol.72 (5), p.e65-e75 [Peer Reviewed Journal]

Crown copyright 2020. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa1728 ;PMID: 33196783

Full text available

13
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
Material Type:
Article
Add to My Research

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England

The New England journal of medicine, 2020-01, Vol.382 (4), p.309-317 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1901229 ;PMID: 31971676

Full text available

14
Global epidemiology of meningococcal disease
Material Type:
Article
Add to My Research

Global epidemiology of meningococcal disease

Vaccine, 2009-06, Vol.27, p.B51-B63 [Peer Reviewed Journal]

2009 ;2009 INIST-CNRS ;Copyright Elsevier Limited Jun 24, 2009 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2009.04.063 ;PMID: 19477562 ;CODEN: VACCDE

Full text available

15
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
Material Type:
Article
Add to My Research

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

New England Journal of Medicine, 2022-01, Vol.386 (4), p.340-350 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2115481 ;PMID: 35021002

Digital Resources/Online E-Resources

16
Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction
Material Type:
Article
Add to My Research

Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction

Clinical infectious diseases, 2016-12, Vol.63 (suppl 4), p.S236-S243 [Peer Reviewed Journal]

The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. ;The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. 2016 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciw559 ;PMID: 27838678

Full text available

17
Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales
Material Type:
Article
Add to My Research

Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales

Clinical infectious diseases, 2015-02, Vol.60 (4), p.578-585 [Peer Reviewed Journal]

Copyright © 2015 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciu881 ;PMID: 25389259

Full text available

18
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
Material Type:
Article
Add to My Research

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

Nature immunology, 2021-05, Vol.22 (5), p.620-626 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature 2021. corrected publication 2021. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-021-00902-8 ;PMID: 33674800

Full text available

19
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
Material Type:
Article
Add to My Research

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

Nature communications, 2021-12, Vol.12 (1), p.7217-7217, Article 7217 [Peer Reviewed Journal]

2021. Crown. ;Crown 2021. corrected publication 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2021, corrected publication 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-27410-5 ;PMID: 34893611

Full text available

20
Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England
Material Type:
Article
Add to My Research

Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England

Emerging infectious diseases, 2022-08, Vol.28 (8), p.1669-1672 [Peer Reviewed Journal]

COPYRIGHT 2022 U.S. National Center for Infectious Diseases ;Published 2022. This article is a U.S. Government work and is in the public domain in the USA. ;2022 ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2808.220304 ;PMID: 35876698

Full text available

Results 1 - 20 of 458  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (395)

Refine My Results

Creation Date 

From To
  1. Before 1985  (13)
  2. 1985 To 1997  (17)
  3. 1998 To 2006  (50)
  4. 2007 To 2016  (122)
  5. After 2016  (256)
  6. More options open sub menu

Language 

  1. English  (451)
  2. Japanese  (30)
  3. French  (10)
  4. German  (8)
  5. More options open sub menu

Searching Remote Databases, Please Wait